title: Rationale for combined hemoperfusion/hemodialysis in uremia.
authors.affiliation: RenalTech International, New York, N.Y., USA. jamesw@renaltech.com
authors.forename: J F
authors.initials: JF
authors.lastname: Winchester
authors.forename: C
authors.initials: C
authors.lastname: Ronco
authors.forename: J A
authors.initials: JA
authors.lastname: Brady
authors.forename: A
authors.initials: A
authors.lastname: Brendolan
authors.forename: V
authors.initials: V
authors.lastname: Davankov
authors.forename: M
authors.initials: M
authors.lastname: Tsyurupa
authors.forename: L
authors.initials: L
authors.lastname: Pavlova
authors.forename: M
authors.initials: M
authors.lastname: Pavlov
authors.forename: J
authors.initials: J
authors.lastname: Clemmer
authors.forename: H D
authors.initials: HD
authors.lastname: Polaschegg
authors.forename: T E
authors.initials: TE
authors.lastname: Muller
authors.forename: G
authors.initials: G
authors.lastname: La Greca
authors.forename: N W
authors.initials: NW
authors.lastname: Levin
mesh_terms: D006464:Hemoperfusion; D006801:Humans; D006435:Renal Dialysis; D014118:Toxins, Biological / Q000302:isolation & purification; D014511:Uremia / Q000378:metabolism / Q000628:therapy*
chemical_list: D014118:Toxins, Biological; C026865:uremia middle molecule toxins